AI uncovers potential treatment for COVID-19

BenevolentAI, a leader in the creation and application of AI and machine learning to transform the way medicines are developed, has announced that baricitinib, which it identified as a potential treatment for COVID-19, will be entering late stage clinical trials to treat the disease

< 1 minute read

Go to Top